Richard Rifkind
#86,076
Most Influential Person Now
American cancer researcher
Richard Rifkind's AcademicInfluence.com Rankings
Richard Rifkindlaw Degrees
Law
#2247
World Rank
#2813
Historical Rank
#1046
USA Rank
Common Law
#107
World Rank
#116
Historical Rank
#20
USA Rank
Richard Rifkindbiology Degrees
Biology
#7527
World Rank
#10464
Historical Rank
#2225
USA Rank
Biochemistry
#1457
World Rank
#1582
Historical Rank
#274
USA Rank
Download Badge
Law Biology
Richard Rifkind's Degrees
- Doctorate Medicine Columbia University
Why Is Richard Rifkind Influential?
(Suggest an Edit or Addition)According to Wikipedia, Richard Rifkind was an American cancer researcher. Rifkind was born in Manhattan, New York, the son of Simon H. Rifkind and his wife Adele . He graduated from the Loomis School in 1948. He graduated from Yale University with a Bachelor of Science degree in 1951. The same year he commenced medical school at Columbia University College of Physicians and Surgeons, graduating in 1955. He served as an intern then as a resident at Presbyterian Hospital. During 1957–59 he also served in the United States Air Force.
Richard Rifkind's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Histone deacetylases and cancer: causes and therapies (2001) (1901)
- Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors (1999) (1580)
- Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. (2000) (1208)
- Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. (2000) (1150)
- A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. (1998) (860)
- Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. (2003) (662)
- Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. (2000) (620)
- Histone deacetylase inhibitors as new cancer drugs (2001) (553)
- The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin (2002) (508)
- Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. (1996) (433)
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. (2001) (355)
- A new group of potent inducers of differentiation in murine erythroleukemia cells. (1976) (317)
- Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. (2001) (283)
- Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. (1977) (235)
- Cloning and characterization of a histone deacetylase, HDAC9 (2001) (235)
- The hepatitis viruses. (1963) (214)
- Erythroleukemic differentiation. (1978) (214)
- Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds. (1975) (204)
- Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. (1999) (200)
- Heinz body anemia: an ultrastructural study. II. Red cell sequestration and destruction. (1965) (197)
- Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. (1977) (173)
- Induction of transformed cells to terminal differentiation and the modulation of gene expression. (1987) (165)
- The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. (2001) (160)
- AN ULTRASTRUCTURAL STUDY OF EARLY MORPHOGENETIC EVENTS DURING THE ESTABLISHMENT OF FETAL HEPATIC ERYTHROPOIESIS (1969) (154)
- Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. (1986) (151)
- Inhibitors of histone deacetylase are potentially effective anticancer agents. (2001) (137)
- Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. (2001) (130)
- Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. (2000) (127)
- Chemically induced murine erythroleukemic differentiation. (1980) (127)
- ELECTRON MICROSCOPIC STUDIES OF EXPERIMENTAL NEPHRITIS WITH FERRITIN-CONJUGATED ANTIBODY : THE BASEMENT MEMBRANES AND CISTERNAE OF VISCERAL EITHELIAL CELLS IN NEPHRITIC RAT GLOMERULI (1962) (123)
- Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. (1992) (122)
- Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. (2000) (122)
- The effect of erythropoietin on colonial growth of erythroid precursor cells in vitro. (1974) (121)
- Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA). (1999) (121)
- Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. (1978) (120)
- Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells (1994) (117)
- Destruction of injured red cells in vivo. (1966) (110)
- Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation. (1977) (109)
- HEINZ BODY ANEMIA--AN ULTRASTRUCTURAL STUDY. I. HEINZ BODY FORMATION. (1965) (109)
- ALTERATIONS IN POLYRIBOSOMES DURING ERYTHROID CELL MATURATION (1964) (102)
- Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation (2007) (100)
- Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. (1994) (99)
- Erythroid cell-development in fetal mice: synthetic capacity for different proteins. (1968) (97)
- Protein Synthesis: Its Control in Erythropoiesis (1972) (96)
- Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle. (1975) (95)
- Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. (2001) (91)
- Erythropoietic differentiation in colonies of cells transformed by Friend virus. (1974) (87)
- Erythroid cell differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds. (1976) (86)
- Murine erythroleukemia cell differentiation: DNase I hypersensitivity and DNA methylation near the globin genes. (1982) (84)
- Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation. (1987) (83)
- DANON D: POLYRIBOSOMES AND PROTEIN SYNTHESIS DURING RETICULOCYTE MATURATION IN VITRO. (1963) (81)
- THE INTRACELLULAR DISTRIBUTION OF GAMMA GLOBULIN IN A MOUSE PLASMA CELL TUMOR (X5563) AS REVEALED BY FLUORESCENCE AND ELECTRON MICROSCOPY (1962) (79)
- Accumulation of α- and β-globin messenger RNAs in mouse erythroleukemia cells (1977) (77)
- STRUCTURE AND DEVELOPMENT OF VIRUSES AS OBSERVED IN THE ELECTRON MICROSCOPE (1961) (74)
- Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds. (1978) (72)
- Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process. (1982) (70)
- Polyribosome dissociation and formation in intact reticulocytes with conservation of messenger ribonucleic acid. (1965) (69)
- THE APPLICATION OF FERRITIN-CONJUGATED ANTIBODY TO ELECTRON MICROSCOPIC STUDIES OF INFLUENZA VIRUS IN INFECTED CELLS (1961) (69)
- ERYTHROPOIETIN EFFECTS ON FETAL MOUSE ERYTHROID CELLS: I. Cell Population and Hemoglobin Synthesis (1971) (66)
- Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. (2003) (65)
- Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation. (1989) (64)
- IMMUNOCHEMICAL STAINING FOR ELECTRON MICROSCOPY (1964) (63)
- Cloning of a D-type cyclin from murine erythroleukemia cells. (1992) (63)
- Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro. (2000) (62)
- Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells. (1977) (60)
- Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals. (1988) (59)
- Gene expression in murine erythroleukemia cells. Transcriptional control and chromatin structure of the alpha 1-globin gene. (1984) (59)
- Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation. (1989) (59)
- Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells. (1998) (59)
- Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors. (2002) (59)
- Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells. (1979) (58)
- Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. (1992) (57)
- Induction of murine erythroleukemia differentiation by actinomycin D. (1978) (55)
- The Use of Ferritin-conjugated Antibodies in Electron Microscopic Studies of Influenza and Vaccinia Viruses (1962) (55)
- Changes in cyclic adenosine 3':5'-monophosphate levels during induction of differentiation in murine erythroleukemia cells. (1978) (54)
- Potent cytodifferentiating agents related to hexamethylenebisacetamide. (1991) (54)
- Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. (1983) (52)
- Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells. (1979) (52)
- Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. (1978) (51)
- Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. (1993) (51)
- Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. (1990) (47)
- Changes in globin messenger RNA content during erythroid cell differentiation. (1975) (46)
- Replication of alpha and beta globin DNA sequences occurs during early S phase in murine erythroleukemia cells. (1981) (46)
- Induced differentiation, the cell cycle, and the treatment of cancer. (1996) (46)
- Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S. (1979) (45)
- Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells. (1980) (41)
- Globin messenger RNA activity in erythroid precursor cells and the effect of erythropoietin. (1972) (40)
- Electron microscopic localization of intracellular viral antigen by the use of ferritin-conjugated antibody. (1961) (40)
- Cell volume changes in relation to the cell cycle of differentiating erythroleukemic cells. (1978) (40)
- Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds. (1996) (39)
- Hematopoiesis in the embryonic mouse spleen: an electron microscopic study. (1972) (39)
- Purification of erythropoietin-responsive cells by immune hemolysis. (1972) (39)
- Erythropoietin effects on fetal mouse erythroid cells. II. Nucleic acid synthesis and the erythropoietin-sensitive cell. (1972) (37)
- Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division. (1983) (37)
- Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation. (1993) (35)
- Photoaffinity Labeling and Mass Spectrometry Identify Ribosomal Protein S3 as a Potential Target for Hybrid Polar Cytodifferentiation Agents* (1999) (32)
- Transcriptional and post-transcriptional regulation of globin gene accumulation in murine erythroleukemia cells (1983) (32)
- Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation. (1978) (32)
- THE APPLICATION OF FERRITIN-CONJUGATED ANTIBODY TO ELECTRON MICROSCOPIC STUDIES OF INFLUENZA VIRUS IN INFECTED CELLS (1961) (31)
- Early stimulation of RNA synthesis by erythropoietin in cultures of erythroid precursor cells. (1973) (30)
- Structure and development of viruses as observed in the electron microscope. VI. ECHO virus, type 9. (1961) (30)
- Erythroid cell development in fetal mice: stabilization of the hemoglobin synthetic capacity. (1970) (28)
- Induced transcription of the mouse β-globintranscription unit in erythroleukemia cells (1984) (28)
- Induction of Transformed Cells to Terminal Differentiation a (1987) (27)
- Fluorescent, Electron Microscopic, and Immunoelectrophoretic Studies of Labeled Antibodies (1963) (26)
- Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells. (1989) (25)
- PHASE CONTRAST AND INTERFEROMETRIC MICROSCOPY OF THE L.E. CELL PHENOMENON (1957) (25)
- Polyribosomes Active in Reticulocyte Protein Synthesis (1963) (23)
- Induced differentiation of murine erythroleukemia cells: cellular and molecular mechanisms. (1984) (21)
- ECHO 9 virus in tissue culture observed by light and electron microscopy. (1960) (21)
- Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential. (1989) (20)
- Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation. (1988) (20)
- Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. (1997) (20)
- SIZE OF POLYRIBOSOMES IN INTACT RETICULOCYTES. (1964) (20)
- Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application. (1988) (20)
- Antigen density on differentiating erythroid cells. (1972) (19)
- Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment. (1984) (19)
- Fundamentals of hematology (1980) (18)
- A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis. (1992) (18)
- Commitment to terminal differentiation and the cell cycle. (1982) (17)
- Hexamethylenebisacetamide-resistant murine erythroleukemia cells have altered patterns of inducer-mediated chromatin changes. (1983) (16)
- Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells. (1992) (16)
- Modulation of gene expression during terminal cell differentiation. (1985) (15)
- Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation. (1991) (15)
- Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression. (1985) (14)
- ELECTRON MICROSCOPIC STUDIES OF EXPERIMENTAL NEPHRITIS WITH FERRITIN-CONJUGATED ANTIBODY (1962) (14)
- Protein kinase C isozymes epsilon and alpha in murine erythroleukemia cells. (1992) (13)
- Induced transcription of the mouse beta-globin transcription unit in erythroleukemia cells. Time-course of induction and of changes in chromatin structure. (1984) (13)
- A DESCRIPTION OF ECHO-9 VIRUS INFECTION IN CULTURED CELLS. II. CYTOCHEMICAL OBSERVATIONS. (1964) (13)
- A DESCRIPTION OF ECHO-9 VIRUS INFECTION IN CULTURED CELLS. I. THE CYTOPATHIC EFFECT. (1964) (13)
- Induction of Murine Erythroleukemia Cells to Differentiate (1978) (11)
- Induction of murine erythroleukemia cells to differentiate: a model for the detection of new anti-tumor drugs. (1978) (11)
- Acute leukemia and cell differentiation. (1986) (11)
- Erythroid differentiation and the cell cycle: some implications from murine foetal and erythroleukemic cells. (1976) (10)
- Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic. (1999) (9)
- ERYTHROPOIETIN EFFECTS ON FETAL MOUSE ERYTHROID CELLS (1971) (9)
- Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells. (1977) (8)
- Induced erythroleukemia differentiation: cellular and molecular aspects. (1987) (8)
- Modulation of gene expression during terminal cell differentiation: murine erythroleukemia. (1984) (8)
- Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory alpha-subunit-like protein whose expression is down-regulated during differentiation. (1999) (8)
- CONTROL OF PROTEIN SYNTHESIS IN RETICULOCYTES AND THE FORMATION OF HEMOGLOBINS A AND F IN THALAESSMIA SYNDROMES AND OTHER HEMOLYTIC ANEMIAS1 (1964) (8)
- Induced differentiation of cancer cells: second generation potent hybrid polar compounds target cell cycle regulators. (1996) (8)
- Control of gene expression during erythroid cell differentiation. (1974) (6)
- Chapter 2 – Erythropoiesis (1974) (6)
- 8 – Erythroleukemia Cells (1992) (6)
- Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. (1986) (6)
- Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycle. (1980) (6)
- Fetal erythropoiesis: erythropoietin effects on cultured cells. (1969) (6)
- Stability of alpha and beta globin messenger RNA during induced differentiation of mouse erythroleukemia cells (1979) (6)
- DNA polymerase activities during induced differentiation in murine erythroleukemia cells. (1981) (5)
- The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Differentiation of Human Breast Cancer Cells 1 (2001) (5)
- Differentiating agents in cancer therapy. (1991) (5)
- A New Technique for the Study of Viruses in the Electron Microscope. (1963) (4)
- Balanced accumulation of α‐ and β‐globin mRNA in differentiating fetal mouse erythroid cells (1978) (4)
- Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC. (1989) (4)
- Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells (1990) (3)
- Regulation of differentiation in transformed erythroid cells. (1978) (3)
- Regulation of differentiation of erythroid cells. (1972) (3)
- Differentiating agents for transformed cells. (1993) (2)
- Regulation of globin gene expression during induced erythroid cell differentiation. (1983) (2)
- THE FERRITIN-CONJUGATED ANTIBODY TECHNIQUE (1962) (2)
- Differentiation and the Role of Differentiation Inducers in Cancer Treatment (2002) (2)
- Regulation of murine ?-, ?major-, and ?minor-globin gene expression (1988) (2)
- Changes in p 34 cdc 2 Kinase Activity and Cyclin A during Induced Differentiation of Murine Erythroleukemia Cells ’ (2005) (1)
- Advances in Brief The Histone Deacetylase Inhibitor , CBHA , Inhibits Growth of Human Neuroblastoma Xenografts in Vivo , Alone and Synergistically with All-Trans Retinoic Acid 1 (2001) (1)
- Commitment: a multi-step process during induced MELC differentiation. (1982) (1)
- Balanced accumulation of alpha- and beta-globin mRNA in differentiating fetal mouse erythroid cells. (1978) (1)
- Differentiating agents in cancer therapy. (1991) (1)
- The regulation of hemoglobin synthesis in the fetal mouse. (1971) (1)
- Commitment, DNA synthesis and gene expression in erythroleukemia cells. (1982) (1)
- Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants. (1990) (1)
- Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation. (1987) (1)
- Conversion ofDifferentiation Inducer Resistance toDifferentiation Inducer Sensitivity inErythroleukemia Cells (1990) (0)
- New potent inducers of terminal differentiation and methods for their use (1990) (0)
- Kombinationen aus Suberoylanilid-Hydroxyaminsäure und Antimetabolika zur Behandlung von Krebs (2004) (0)
- Methode de traitement des maladies mediees par la thioredoxine (trx) (2003) (0)
- Biochemical aspects of the pathogenesis of the thalassemia syndromes. (1973) (0)
- 119. Hexamethylene bisacetamide (HMBA)-induced reduction in diacylglycerol levels is associated with differentiation of murine erythroleukemia cells (1992) (0)
- Perspectivesin CancerResearch Induction of Transformed Cells to Terminal Differentiation and the Modulation of Gene Expression1 (2006) (0)
- I. Heinz Body Formation (2016) (0)
- 162. Phase II clinical trial with hexamethylene bisacetamide (HMBA) in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML) (1992) (0)
- Replication of a and .8 globin DNA sequences occurs during early S phase in murine erythroleukemia cells (0)
- Approaches to more effective induction of cytodifferentiation of transformed cells and potential for cancer treatment. (1990) (0)
- Gene expression during terminal differentiation: Dexamethasone suppression of inducer-mediated cal- and pma-globin gene expression division/chromatin/hexamethylenebisacetamlde/ gene transcription i/erythroleukemia) (2003) (0)
- Stability of alpha and beta globin messenger RNA during induced differentiation of mouse erythroleukemia cells. (1979) (0)
- The erythropoietin-responsive cell. Abstr. (1971) (0)
- Computer-assisted medical instruction. (1973) (0)
- [The molecular pathogenesis of the thalassemia syndromes (author's transl)]. (1975) (0)
- Globin messenger RNA content during erythroid cell differentiation. (1974) (0)
- 76. Membrane alterations associated with hexamethylene bisacetamide (HMBA) induced differentiation of murine erythroleukemia cells (MELC) (1992) (0)
- Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBA. (1984) (0)
- Response : Fetal Liver Erythropoiesis and Yolk Sac Cells (1972) (0)
- The new medicine: experiments in medical education. (1971) (0)
- differentiation: A multistep process (Friend virus/chromatin protein/dexamethasone/globin mRNA/hemi (2016) (0)
- Protein kinase C isozymes e and a in murine erythroleukemia cells (2004) (0)
- Murine Erythroleukemia: Cell Surface and Cell Cycle-Related Events in Induced Differentiation (1978) (0)
- Regulation of murine alpha-, beta major-, and beta minor-globin gene expression. (1988) (0)
- DRIFT INSTABILITIES IN CYLINDRICAL DISCHARGES INVOLVING BOTH IONS AND ELECTRONS (2003) (0)
- Implications of cellular molecular biology to the management of cancer. (1989) (0)
- Murine erythroleukemia cell differ4 hypersensitivity and DNA methylal the globin genes (2016) (0)
- The pharmacology of cell differentiation : proceedings of the Esteve Foundation Symposium V, Son Vida, Mallorca, 12-15 October, 1992 (1993) (0)
- Induced Differentiation of Transformed Cells by Polar Compounds: From Molecular Studies to Clinical Trials (1989) (0)
- Phase I Clinical Trial of Histone Deacetylase Inhibitor : Suberoylanilide Hydroxamic Acid Administered Intravenously 1 (2003) (0)
- FERRITIN-CONJUGATED ANTIBODY AND CELL SURFACE (2003) (0)
- Changes in DMA Associated with Induction of Erythroid Differentiation by Dimethyl Sulfoxide in Murine Erythroleukemia Cells 1 (2006) (0)
- Clinical Excellence and Research: One and Indivisible (1994) (0)
- Expression of erythroid differentiation and terminal cell division in induced Friend leukemia cells. (1981) (0)
- Restriction endonuclease sensitivity of DNA containing globin genes in different murine erythroleukemia cell lines. (1981) (0)
- A DESCRIPTION OF ECHO-9 VIRUS INFECTION (2007) (0)
- New efficient, terminal differentiation-inducing agents, and methods for their use (1994) (0)
- Role of differentiation induction in tumor suppression. (1990) (0)
This paper list is powered by the following services:
Other Resources About Richard Rifkind
What Schools Are Affiliated With Richard Rifkind?
Richard Rifkind is affiliated with the following schools:
